Mezzion Pharma (140410) | AccidentalOrder

KOSDAQ · 66,300 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

2.0T

Op Inc (2025)

-16.8B

Net Inc (2025)

-34.9B

PBR

118.07

52W

40K~172K

Mezzion Pharma operates in the Professional Services sector.

Legal name: Mezzion Pharma Co., Ltd.

Operating profit was -16.8 billion KRW and net income was -34.9 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 2.03 trillion KRW, with a P/B of 118.07.

These figures can be verified in the DART filing (receipt no. 20260320001282).

Year	Rev	Op Inc	Net Inc
2025	—	-16.8B	-34.9B
2024	—	-14.3B	-19.5B
2023	—	-14.5B	-12.7B

3 applicable out of 8 items

Semi-Annual Report (2026.06)

Officer/Major Shareholder Ownership Report

Checks

3 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.03% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: 2 embezzlement/litigation filing(s) in the last 180 days. [source]

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Semi-Annual Report (2026.06)
2026-08-06	Officer/Major Shareholder Ownership Report
2026-08-06	Officer/Major Shareholder Ownership Report
2026-08-06	Officer/Major Shareholder Ownership Report